Az eritropoetin új lehetoség a kissejtes tüdodaganat okozta anémia kezelésében - Esetbemutatás

Translated title of the contribution: Erythropoietin is a novel therapeutic option in the treatment of anemia caused by small cell lung cancer

Lilla Tamási, Anikó Bohács, András Wollák, Pál Magyar

Research output: Contribution to journalArticle


Anemia is very common among patients with malignant tumors, due to the disease and chemotherapy. Anemia decreases the patient's quality of life. Erythropoietin therapy is accessible in Hungary for the treatment of chemotherapy-induced anemia in patients suffering from small cell lung cancer. In our case report we present the case of a 62-year-old female small cell lung cancer patient with severe anemia, treated by erythropoietin-beta. The erythropoietin treatment provided the possibility of effective chemo- and radiotherapy. The patient's quality of life greatly improved due to the lack of the symptoms of anemia. The adequate use of erythropoietin is of great help to the physician in the management of small cell lung cancer patients, by improving the quality of life.

Original languageHungarian
Pages (from-to)243-246
Number of pages4
JournalMagyar onkologia
Issue number3
Publication statusPublished - Dec 1 2006


ASJC Scopus subject areas

  • Medicine(all)

Cite this